Edwards Lifesciences Corp · Healthcare
Edwards Lifesciences Corp (EW) is a stock traded in US markets in the Healthcare sector. P/E 51.20, P/B 4.69, ROE 9.26% and dividend yield not disclosed. The P/E multiple helps compare this asset's valuation with other companies in the same sector. Explore the public market data tracked by FundamentalRadar. This page includes key fundamental indicators, recent distributions and financial statements available from the public sources tracked by FundamentalRadar.
The source returned no recent distributions for this asset.
Financial statements are not available for this asset yet.
The current price of EW is $86.29.
The P/E ratio of EW is 51.20, meaning investors pay 51.20 times earnings per share.
The P/B of EW is 4.69, meaning the stock trades at 4.69 times its book value per share.
The ROE (Return on Equity) of EW is 9.26%, meaning the company generates 9.26% of profit for every unit of shareholders' equity.
The market capitalization of EW is US$ 49.7 B.
The net profit margin of EW is 15.05%, meaning the company keeps 15.05% of revenue as profit.
The debt-to-equity ratio of EW is 0.07, meaning the company has 0.07 units of debt for each unit of equity.
EW operates in the Healthcare sector.